- 2026-03-18 15:02PCTR1 1810710-59-8
- 2026-03-18 15:02PBR28 253307-65-2
- 2026-03-18 15:02PBD dimer-2 145325-57-1
- 2026-03-18 15:02PB2 914940-24-2
- 2026-03-18 15:01PB1 188714-28-5
- 2026-03-18 15:01Paucimannose 70858-45-6
- 2026-03-18 15:01PAT1inh-B01 1775330-54-5
- 2026-03-18 15:01Pantothenate kinase-IN-2 902614-04-4
- 2026-03-18 15:01Pandamine 10233-81-5
- 2026-03-18 15:01P7C3-OMe 313268-18-7
- 2026-03-18 15:01p-SCN-Bn-DOTA 127985-74-4
- 2026-03-18 15:01p-SCN-Bn-deferoxamine 1222468-90-7
- 2026-03-18 15:01p-Cresolglucuronide 17680-99-8
- 2026-03-18 15:01p-APMSF hydrochloride (p-Amidinophenylmethylsulfonylfluoride hydrochloride) 74938-88-8
- 2026-03-18 15:01OY-201 2962943-05-9
- 2026-03-18 15:01Oxypalmatine (8-Oxypalmatine) 19716-59-7
- 2026-03-18 15:01OXS007417 2761147-94-6
- 2026-03-18 15:00Oxolamine citrate (Oxolamine citrate; SKF-9976 citrate; AF-438 citrate) 1949-20-8
- 2026-03-18 15:00OU749 519170-13-9
- 2026-03-18 15:00OT antagonist 3 analog 2444044-37-3
